-
People who opt for nonsmoking rooms in hotels with a partial smoking ban are not fully protected from harmful exposure to so-called "thirdhand" smoke, according to a new study.More >> People who opt for nonsmoking rooms in hotels with a partial smoking ban are not fully protected from harmful exposure to so-called "thirdhand" smoke, according to a new study.More >> New research suggests the dominant side of your brain may make the call on which ear you choose to use while talking on your cellphone.More >> New research suggests the dominant side of your brain may make the call on which ear you choose to use while talking on your cellphone.More >> Scientists report that they were able to improve the math-calculation skills of college students by buzzing their brains with doses of random high-frequency noise.More >> Scientists report that they were able to improve the math-calculation skills of college students by buzzing their brains with doses of random high-frequency noise.More >> As many as one in five American children under the age of 17 has a diagnosable mental disorder in a given year, according to a new federal report.More >> As many as one in five American children under the age of 17 has a diagnosable mental disorder in a given year, according to a new federal report.More >>
-
People who take certain types of antidepressants may be at higher risk for potentially deadly Clostridium difficile infection, a new study suggests.More >> People who take certain types of antidepressants may be at higher risk for potentially deadly Clostridium difficile infection, a new study suggests.More >> Patients who take antihistamines to reduce stomach acid are at increased risk for infection with Clostridium difficile, a common cause of diarrhea, a new study finds.More >> Patients who take antihistamines to reduce stomach acid are at increased risk for infection with Clostridium difficile, a common cause of diarrhea, a new study finds.More >> Gastric bypass surgery may help people lose weight by changing the makeup of bacteria living in the intestines, suggests a new study conducted in mice.More >> Gastric bypass surgery may help people lose weight by changing the makeup of bacteria living in the intestines, suggests a new study conducted in mice.More >> The first five patients to try a new, minimally invasive weight-loss procedure dropped an average of more than 45 pounds in six months, researchers report.More >> The first five patients to try a new, minimally invasive weight-loss procedure dropped an average of more than 45 pounds in six months, researchers report.More >>
THURSDAY, Aug. 30 (HealthDay News) -- Linzess (linaclotide) has been approved by the U.S. Food and Drug Administration to treat forms of chronic constipation that don't respond to traditional treatment, and irritable bowel syndrome accompanied by constipation, the agency said Thursday in a news release.
The National Institutes of Health estimates that some 63 million people are affected by chronic constipation, and about 15.3 million have irritable bowel syndrome (IBS), the FDA said.
Linzess is taken once daily on an empty stomach, at least 30 minutes before the first meal. The most frequently noted adverse reaction is diarrhea.
The drug's label contains a boxed warning that it shouldn't be taken by people aged 16 or younger, the FDA said.
Linzess is produced by Cambridge, Mass.-based Ironwood Pharmaceuticals.
More information
Medline Plus has more about constipation.
Copyright © 2012 HealthDay. All rights reserved.
